Epidemiological and Immunogenetic Studies of Multiple Sclerosis in Japan

  • Y. Kuroiwa


Multiple sclerosis (MS) is distributed over the world in a unique geographical pattern, with Japan and other Asian countries belonging to the low risk areas. Systematic prevalence studies, besides those of Japan [9], are lacking. Some reports of the clinical manifestations suggest a modification in Asian MS [2, 3, 16]. Since the environmental factors differ immensely between Asia (Japan) and the West, it is essential to cover these areas in obtaining various epidemiological parameters.


Multiple Sclerosis Northern City Acute Transverse Myelitis Multiple Sclerosis Susceptibility Measle Antibody 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Detels R, Visscher BR, Malmgren RM, Coulson AH, Lucia MV, Dudley JP (1977) Evidence for lower susceptibility to multiple sclerosis in Japanese-Americans. Am J Epidemiol 105:303–310PubMedGoogle Scholar
  2. 2.
    Hung TP, Landsborough D (1976) Multiple sclerosis amongst Chinese in Taiwan. J Neurol Sci 27:459–484PubMedCrossRefGoogle Scholar
  3. 3.
    Kuroiwa Y, Shibasaki H (1973) Clinical studies of multiple sclerosis in Japan. Neurology (Minneap) 23:609–617Google Scholar
  4. 4.
    Kuroiwa Y, Shibasaki H (1976) Epidemiologic and clinical studies of multiple sclerosis in Japan. Neurology (Minneap) 26(6–2): 8–10Google Scholar
  5. 5.
    Kuroiwa Y, Igata A, Itahara K, Koshijima S, Tsubaki T, Toyokura Y, Shibasaki H (1975) Nationwide survey of multiple sclerosis in Japan. Clinical analysis of 1084 cases. Neurology (Minneap) 25:845–851Google Scholar
  6. 6.
    Kuroiwa Y, Hung TP, Landsborough D, Park CS, Singhal S, Soemargo S, Vejjajiva A, Shibasaki H (1977) Multiple sclerosis in Asia. Neurology (Minneap) 27:188–192Google Scholar
  7. 7.
    Mathews WB (1975) Paroxysmal symptoms in multiple sclerosis. J Neurol Neurosurg Psychiatry 38:617–623CrossRefGoogle Scholar
  8. 8.
    Naito S, Namerrow N, Mickey MR, Terasaki PI (1972) Multiple sclerosis: Association with HL-A3. Tissue Antigens 2:1–4PubMedCrossRefGoogle Scholar
  9. 9.
    Okinaka S, Kuroiwa Y (1966) Multiple sclerosis and allied diseases in Japan: Epdemiological and clinical aspects. Prog Brain Res 21:183–191PubMedCrossRefGoogle Scholar
  10. 10.
    Okinaka S, Tsubaki T, Kuroiwa Y, Toyokura Y, Imamura Y, Yoshikawa M (1958) Multiple sclerosis and allied diseases in Japan. Neurology (Minneap) 8:756–763Google Scholar
  11. 11.
    Osuntoken BO (1971) The pattern of neurological illness in tropical Africa. Experience at Ibadan, Nigeria. J Neurol Sci 12:417–442CrossRefGoogle Scholar
  12. 12.
    Saito S, Naito S, Kawanami S, Kuroiwa Y (1976) HLA studies on multiple sclerosis in Japan. Neurology (Minneap) 26(6–2): 49Google Scholar
  13. 13.
    Sasazuki T, Ohono Y, Iwamoto I (1976) Association of HLA-D antigens with multiple sclerosis. In: Kuroiwa Y (ed) Annual report of MS research committee, Japan, Min Health Welfare Japan, pp 153–156Google Scholar
  14. 14.
    Shibasaki H, Kuroiwa Y (1974) Painful tonic seizure in multiple sclerosis. Arch Neurol 30:47–51PubMedGoogle Scholar
  15. 15.
    Shibasaki H, Okihiro M, Kuroiwa Y (1978) Multiple sclerosis among Orientals and Caucasians in Hawaii: A reappraisal. Neurology (Minneap) 28:113–118Google Scholar
  16. 16.
    Singhai BS, Wadia NH (1975) Profile of multiple sclerosis in the Bombay region on the basis of critical clinical appraisal. J Neurol Sci 26:259–270CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1980

Authors and Affiliations

  • Y. Kuroiwa
    • 1
  1. 1.Department of Neurology, Neurological Institute, Faculty of MedicineKyushu UniversityFukuoka, 812Japan

Personalised recommendations